HealthRx and Mochi both compete for telehealth weight-management patients, but their pricing models are not identical. HealthRx emphasizes bundled plan pricing; Mochi currently advertises lower starting medication prices that vary by dose.
Pricing model
HealthRx advertises compounded semaglutide from $99/month and tirzepatide from $179/month on 12-month prepaid plans. Mochi's current site advertises compounded semaglutide starting at $60 and compounded tirzepatide starting at $90, with price varying by dose. Compare total program fees, membership charges and dose-related changes before deciding.
Medication pathway
Both services advertise compounded GLP-1 options. Mochi also promotes brand-name medication pathways. That can matter if your preference is to start with—or transition to—an FDA-approved product rather than a compounded preparation.
Who might prefer HealthRx
HealthRx may appeal to someone who values a published bundled cash-pay price and is comfortable with a longer prepaid commitment to obtain the lowest monthly equivalent.
Who might prefer Mochi
Mochi may appeal to someone who wants a program with both branded and compounded pathways or who prefers its dose-based pricing structure.
Before choosing
Verify the current plan terms on both sites. Compounded products are not FDA-approved, and treatment should proceed only after clinician review.
Sources & verification
We use primary sources for time-sensitive commercial and regulatory claims.
- HealthRx — Pricing
- HealthRx — About & compounded-medication disclosure
- Mochi Health — Weight-loss program
- FDA — Concerns with unapproved GLP-1 drugs used for weight loss
Last reviewed: August 19, 2026